Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial

Recruiting now · Not applicable

Conditions studied: The Efficacy and Safety for Super High-flux Dialyzer in Case of Sepsis in ESKD, End Stage Kidney Disease (ESRD), Sepsis

In brief

Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.

Key facts

Study ID

NCT06989892

Run by

Navamindradhiraj University

People needed

202

Starts

2024-07-25

Expected to finish

2026-10-01

Last updated by the study team

2025-05-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ESKD patients who have sepsis condition with high interleukin-6 (IL-6 > 50 pg/ml)

You may not qualify if…

• Patients who needed dialysis with continuous kidney replacement therapy, vulnerable patient, include pregnant woman, patient who expected to pass away within the 24 hours.
• Patients who have the history of allergic dialyzer reaction to dialyzer which used in this trial.

Where it is running

• Navamindhradhiraj university — Dusit, Bangkok, Thailand (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.